# FDA Inspection 772796 - Altaire Pharmaceuticals, Inc. - March 19, 2012

Source: https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/1eebc50a-1b89-4b77-98da-2d6c7024ff14
Source feed: FDA_Inspections

> FDA Inspection 772796 for Altaire Pharmaceuticals, Inc. on March 19, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 772796
- Company Name: Altaire Pharmaceuticals, Inc.
- Inspection Date: 2012-03-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1251507 - 2024-10-21](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/52c9de95-f12f-4b35-af57-5eadb622e6a6)
- [FDA Inspection 1251507 - 2024-10-21](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/b61fd512-2687-4ca8-8d73-1cfa85e5c680)
- [FDA Inspection 1162640 - 2022-02-11](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/0c20c70c-b178-4306-8b90-55ba5c3ee376)
- [FDA Inspection 1162640 - 2022-02-11](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/05e433a1-838b-41ab-8c34-777aa069c24d)
- [FDA Inspection 1089315 - 2019-04-19](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/8e903be8-7abd-43af-8de9-de234d782298)

Company: https://www.keypedia.com/companies/altaire-pharmaceuticals-inc/1e892910-1e24-4697-87c3-61cc48735f49

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c